These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

500 related items for PubMed ID: 23117024

  • 1. Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs.
    Zhang L, Yao J, Zhou J, Wang T, Zhang Q.
    Int J Pharm; 2013 Jan 30; 441(1-2):654-64. PubMed ID: 23117024
    [Abstract] [Full Text] [Related]

  • 2. Improved anti-tumor activity and safety profile of a paclitaxel-loaded glycyrrhetinic acid-graft-hyaluronic acid conjugate as a synergistically targeted drug delivery system.
    Zhang L, Zhou JP, Yao J.
    Chin J Nat Med; 2015 Dec 30; 13(12):915-24. PubMed ID: 26721710
    [Abstract] [Full Text] [Related]

  • 3. Efficient simultaneous tumor targeting delivery of all-trans retinoid acid and Paclitaxel based on hyaluronic acid-based multifunctional nanocarrier.
    Yao J, Zhang L, Zhou J, Liu H, Zhang Q.
    Mol Pharm; 2013 Mar 04; 10(3):1080-91. PubMed ID: 23320642
    [Abstract] [Full Text] [Related]

  • 4. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin.
    Mezghrani O, Tang Y, Ke X, Chen Y, Hu D, Tu J, Zhao L, Bourkaib N.
    Int J Pharm; 2015 Jan 30; 478(2):553-68. PubMed ID: 25455765
    [Abstract] [Full Text] [Related]

  • 5. Hepatocellular Carcinoma Targeting and Pharmacodynamics of Paclitaxel Nanoliposomes Modified by Glycyrrhetinic Acid and Ferric Tetroxide.
    Zhao L, Liang L, Guo M, Li M, Yu X, Wang Y, Wang Y.
    Curr Top Med Chem; 2021 Oct 05; 21(14):1268-1284. PubMed ID: 34620053
    [Abstract] [Full Text] [Related]

  • 6. Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer.
    Yang XY, Li YX, Li M, Zhang L, Feng LX, Zhang N.
    Cancer Lett; 2013 Jul 01; 334(2):338-45. PubMed ID: 22776563
    [Abstract] [Full Text] [Related]

  • 7. Enhanced delivery of doxorubicin to the liver through self-assembled nanoparticles formed via conjugation of glycyrrhetinic acid to the hydroxyl group of hyaluronic acid.
    Wang X, Gu X, Wang H, Yang J, Mao S.
    Carbohydr Polym; 2018 Sep 01; 195():170-179. PubMed ID: 29804965
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hydrotropic hyaluronic acid conjugates: Synthesis, characterization, and implications as a carrier of paclitaxel.
    Saravanakumar G, Choi KY, Yoon HY, Kim K, Park JH, Kwon IC, Park K.
    Int J Pharm; 2010 Jul 15; 394(1-2):154-61. PubMed ID: 20438818
    [Abstract] [Full Text] [Related]

  • 11. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel.
    Li J, Huo M, Wang J, Zhou J, Mohammad JM, Zhang Y, Zhu Q, Waddad AY, Zhang Q.
    Biomaterials; 2012 Mar 15; 33(7):2310-20. PubMed ID: 22166223
    [Abstract] [Full Text] [Related]

  • 12. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
    Qi WW, Yu HY, Guo H, Lou J, Wang ZM, Liu P, Sapin-Minet A, Maincent P, Hong XC, Hu XM, Xiao YL.
    Mol Pharm; 2015 Mar 02; 12(3):675-83. PubMed ID: 25584860
    [Abstract] [Full Text] [Related]

  • 13. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.
    Liu Y, Sun J, Cao W, Yang J, Lian H, Li X, Sun Y, Wang Y, Wang S, He Z.
    Int J Pharm; 2011 Dec 12; 421(1):160-9. PubMed ID: 21945183
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The anti-tumor performance of docetaxel liposomes surface-modified with glycyrrhetinic acid.
    Li J, Xu H, Ke X, Tian J.
    J Drug Target; 2012 Jun 12; 20(5):467-73. PubMed ID: 22577855
    [Abstract] [Full Text] [Related]

  • 16. Self-aggregated nanoparticles of linoleic acid-modified glycol chitosan conjugate as delivery vehicles for paclitaxel: preparation, characterization and evaluation.
    Yu J, Liu Y, Zhang L, Zhao J, Ren J, Zhang L, Jin Y.
    J Biomater Sci Polym Ed; 2015 Jun 12; 26(18):1475-89. PubMed ID: 26489688
    [Abstract] [Full Text] [Related]

  • 17. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C, Gu B, Xie C, Li J, Liu Y, Lu W.
    J Control Release; 2010 Apr 02; 143(1):136-42. PubMed ID: 20056123
    [Abstract] [Full Text] [Related]

  • 18. Redox-responsive micelles from disulfide bond-bridged hyaluronic acid-tocopherol succinate for the treatment of melanoma.
    Xia J, Du Y, Huang L, Chaurasiya B, Tu J, Webster TJ, Sun C.
    Nanomedicine; 2018 Apr 02; 14(3):713-723. PubMed ID: 29317344
    [Abstract] [Full Text] [Related]

  • 19. Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery.
    Tian Q, Zhang CN, Wang XH, Wang W, Huang W, Cha RT, Wang CH, Yuan Z, Liu M, Wan HY, Tang H.
    Biomaterials; 2010 Jun 02; 31(17):4748-56. PubMed ID: 20303163
    [Abstract] [Full Text] [Related]

  • 20. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y, Zhang J, Cheng R, Deng C, Meng F, Xie F, Zhong Z.
    J Control Release; 2015 May 10; 205():144-54. PubMed ID: 25596560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.